BioNTech SE Cash Flows From Used In Financing Activities
BioNTech SE (BNTX) reported Cash Flows From Used In Financing Activities of -EUR 52.90 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-10
| Period end | Cash Flows From Used In Financing Activities 12 month | Cash Flows From Used In Financing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | -52.90M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -45.90M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -778.60M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | -1.42B EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 94.20M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 894.70M EUR 20-F · filed 2023-03-27 | 894.73M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 383.30M EUR 20-F/A · filed 2022-10-26 | 383.29M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 365.18M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -1.64M EUR 20-F · filed 2020-03-31 |